Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Ospemifene for Vaginal Atrophy in Postmenopausal Women
NCT00729469Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ospemifene in vulvovaginal atrophy (VVA), sponsored by Shionogi & Co., Ltd.. Started Jul 2008; status: completed.
02
Drugs
ospemifene
03
Conditions
vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT00729469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729469.